Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris

Pediatric Infectious Disease Journal

Volumn 16, Issue 6, 1997, Pages 545-548

  Bakos, Lúcio ^a   Brito, Arival C ^b   Castro, Lia Candida M ^c   Gontijo, Bernardo ^d   Lowy, Gabriela ^e   Reis, Carmélia Matos Santiago ^f   Ribeiro, Aurélio Marcos ^g   Souza, Francisco Helder Cavalcante ^h   Villar, Maria Do Livramento ⁱ   Zaitz, Clarisse ^j  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f UNIVERSITY OF BRASILIA   (Brazil)

^g Cutis Clin Dermatologica Clin   (Brazil)

^h USP   (Brazil)

ⁱ FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^j Medical Sciences School of Santa Casa of São Paulo   (Brazil)

more..

Author keywords

Terbinafine; Tinea corporis; Tinea cruris

Indexed keywords

TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRURITUS; TINEA CORPORIS; TINEA CRURIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NAPHTHALENES; TINEA;

EID: 0030983273     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199706000-00002     Document Type: Article

References (11)

1. Minelli L, Minelli HJ. Dermatoses na infância: estudo estatístico de 6000 casos. An Bras Dermatol 1992;67:15-8.
2. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992;43:259-84.
3. Cordero C, de la Rosa I, Espinosa Z, Rojas RF, Zaias N. Short-term therapy of tinea cruris/corporis with topical terbinafine. J Dermatol Treat 1992;3(Suppl 1):23-4.
4. Cucé LC, Bakos L, Campbell I, et al. Eficácia e tolerabilidade da terbinafina creme a 1% uma vez ao dia, durante uma semana, em tinea corporis/cruris. Dermatologia 1993;1:10-16.
5. El-Mansy I, Halim S. Efficacy of one week terbinafine (Lamisil®) 1% cream in the treatment of tinea cruris/corporis. Egypt J Dermatol Venereol 1994;14:99-104.
6. Mayser P, Langenscheidt F, Gründer K, Schill WB. Onychomykose durch Trichophyton mentagrophytes var. quinckeanum: erfolgreiche Therapie mit Terbinafin-Creme. Z Hautkrankh 1994;69:619-21.
7. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992;126(Suppl 39):2-7.
8. Evans EGV, Shah JM, Joshipura RC. One-week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil®) 1% cream: a placebo-controlled study. J Dermatol Treat 1992;3: 181-4.
9. Jones TC. Treatment of dermatomycosis with topically applied allylamines: naftifine and terbinafine: J Dermatol Treat 1992;1(Suppl 2):29-32.
10. Zaias N, Berman B, Cordero CN, et al. Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis. J Am Acad Dermatol 1993;29:646-8.
11. Evans EGV, Dodman B, Williamson DM, Brown GJ, Bowen, RG. Comparison of terbinafine and clotrimazole in treating tinea pedis. Br Med J 1993;307:645-7.